Stocks · News reference
Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed as Dow fell ~100 points; Silence Therapeutics surged 125.7% on Merck KGaA buyout, while biotech and tech shares gained.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Kaplan Fox Encourages Investors of AST SpaceMobile, Inc. (NASDAQ: ASTS) Who Suffered Losses to Contact the Firm Before November 13, 2026
Kaplan Fox has filed securities class action lawsuits against AST SpaceMobile (ASTS), AppLovin (APP), and Bank of America (BAC) on behalf of investors who suffered losses. AST is accused of overstating its competitive advantages in the satellite D2C market and capital sufficiency. AppLovin's class period spans February to August 2026, and Bank of America's spans August 2025 to October 2026. Investors have until specified deadlines to seek lead plaintiff status.
Veradermics Eyes Historic FDA First After Strong Hair Loss Pill Trial Results
Veradermics reports positive Phase 2/3 trial data for its oral hair loss pill, paving the way for potential FDA approval. MANE shares rise.
CNH Industrial, Planet Labs, Ferguson Enterprises And Other Big Stocks Moving Higher On Monday
U.S. stocks rallied Monday; CNH surged 13.5% after strong Q3 results and raised guidance, while several stocks posted double-digit gains.
Guggenheim Initiates Coverage On Disc Medicine with Buy Rating, Announces Price Target of $132
8-K filing — UNITED STATES ANTIMONY CORP (UAMY)
Filed: 2026-11-09 AccNo: 0001104659-26-124277 Size: 266 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits